EUVIMEDEUVIMED entdecken
Crossref

‘A sigh of relief’: New malaria drug succeeds in clinical trial as existing treatments falter

Kai Kupferschmidt

Science · 2025

DOI: 10.1126/science.aee0352 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, 2025. Verfasst von Kai Kupferschmidt. Beteiligte Einrichtung: Toronto. Hauptthemen laut MEDLINE: Antimalarials, Malaria, Malaria, Falciparum, Plasmodium falciparum.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ganaplacide, developed by Novartis, eases worries about drug resistance—but hard choices loom on how to use it

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsMalariaMalaria, FalciparumPlasmodium falciparumImidazolesPiperazinesDrug DevelopmentHumansClinical Trials as TopicDrug ResistanceTanzania

Substanzen

AntimalarialsganaplacideImidazolesPiperazines

Autor:innen und Institutionen

  • Toronto.

Zitieren

APA

Kupferschmidt, K. (2025). ‘A sigh of relief’: New malaria drug succeeds in clinical trial as existing treatments falter. Science. https://doi.org/10.1126/science.aee0352

Vancouver

Kupferschmidt K. ‘A sigh of relief’: New malaria drug succeeds in clinical trial as existing treatments falter. Science. 2025. doi:10.1126/science.aee0352

BibTeX
@article{Kupferschmidt2025,
  author = {Kupferschmidt, Kai},
  title = {‘A sigh of relief’: New malaria drug succeeds in clinical trial as existing treatments falter},
  journal = {Science},
  year = {2025},
  doi = {10.1126/science.aee0352}
}
Kostenlos starten →